Latest News in the pharma Industry
Top Stories
Eli Lilly announces expansion of Indianapolis R&D headquarters
2 Nov 2015
New building to feature collaboration-focused workspace.
Read more
Biogen Q3 2015 revenues increase 11% to $2.8 billion
22 Oct 2015
Corporate restructuring to result in an 11% workforce reduction.
Read more
Lilly to discontinue development of evacetrapib for high-risk atherosclerotic cardiovascular disease
12 Oct 2015
Phase III trial terminated due to insufficient efficacy.
Read more
NIH grantees win 2015 Nobel Prize in chemistry
7 Oct 2015
Prize awarded for mapping, at a molecular level, how cells repair damaged DNA and safeguard the genetic information.
Read more
FTC files amicus brief explaining that pharmaceutical “product hopping” can violate the antitrust laws
2 Oct 2015
The FTC filed its amicus brief in a private antitrust action in which Mylan Phamraceuticals Inc. alleges that Warner Chilcott PLC/Mayne Pharma Group maintained a monopoly in the market for its antibiotic Doryx by suppressing generic competition through...
Read more
National Biologics Manufacturing Centre launched
1 Oct 2015
The new centre will provide companies with open access facilities and expertise to help them develop, prove and commercialise new and improved processes and technologies for biologics manufacture.
Read more
CPhI Worldwide; shortlisted finalists for the 2015 Pharma Awards
23 Sep 2015
Winners from all 7 categories will be unveiled live at the event in Madrid.
Read more
Swissmedic approves Novartis' new heart failure medicine Entresto
22 Sep 2015
Decision by Swiss Health Authority follows FDA approval of Entresto in July, and serves as an important reference approval for multiple other health authorities.
Read more
FDA approves new drug to treat schizophrenia and bipolar disorder
22 Sep 2015
Vraylar is an atypical antipsychotic, for the acute treatment of manic or mixed episodes associated with bipolar I disorder and for treatment of schizophrenia in adults.
Read more
Bausch + Lomb and Nicox announce FDA Acceptance of NDA for novel glaucoma candidate
22 Sep 2015
If approved, Vesneo will be the first nitric oxide donating prostaglandin receptor agonist available for patients with open angle glaucoma or ocular hypertension.
Read more
Novo Nordisk to build manufacturing facility in Iran
22 Sep 2015
The plant will manufacture FlexPen prefilled devices.
Read more
Envigo opens its doors for business on 21 September
21 Sep 2015
Envigo has been created through the integration of Huntingdon Life Sciences, Harlan Laboratories, GFA, NDA Analytics and LSR associates.
Read more